Trial Profile
Relative Bioavailability of Single Doses of 150 mg Dabigatran Etexilate (Capsule) When Administered Alone or in Combination With a Single Dose of 400 mg Ketoconazole (Tablet) or in Combination With 400 mg q.d. Ketoconazole (Tablet) at Steady State in Healthy Male and Female Volunteers (an Open Label, Fixed Sequence, Phase I Study)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Jun 2014
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Ketoconazole
- Indications Deep vein thrombosis; Embolism; Pulmonary embolism; Stroke; Venous thromboembolism
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 26 Jun 2014 New trial record